van Roeden, S EWever, P CKampschreur, L MGruteke, PVan Der Hoek, WHoepelman, A I MBleeker-Rovers, C POosterheert, J J2019-03-052019-03-052018-12-101469-06913054385210.1016/j.cmi.2018.11.023http://hdl.handle.net/10029/622868Chronic infection with Coxiella burnetii (chronic Q fever) can cause life-threatening conditions such as endocarditis, infected vascular prostheses, and infected arterial aneurysms. We aimed to assess prognosis of chronic Q fever patients in terms of complications and mortality. A large cohort of chronic Q fever patients was assessed to describe complications, overall mortality and chronic Q fever-related mortality. Chronic Q fever-related mortality was expressed as a case fatality rate (number of chronic Q fever-related deaths/number of chronic Q fever patients). Complications occurred in 166 of 439 (38%) chronic Q fever patients: in 61% of proven (153/249), 15% of probable (11/74), and 2% of possible chronic Q fever patients (2/116). Most frequently observed complications were acute aneurysms (14%), heart failure (13%), and non-cardiac abscesses (10%). Overall mortality was 38% (94/249) for proven chronic Q fever patients (median follow-up 3.6 years) and 22% (16/74) for probable chronic Q fever patients (median follow-up 4.7 years). The case fatality rate was 25% for proven (63/249) chronic Q fever patients and 4% for probable (3/74) chronic Q fever patients. Overall survival was significantly lower in patients with complications, compared to those without complications (p <0.001). In chronic Q fever patients, complications occur frequently and contribute to the mortality rate. Patients with proven chronic Q fever have the highest risk of complications and chronic Q fever-related mortality. Prognosis for patients with possible chronic Q fever is favourable in terms of complications and mortality.eninfo:eu-repo/semantics/closedAccessComplicationsCoxiella burnetiiEndocarditisInfected vascular prosthesisMortalityMycotic aneurysmQ feverChronic Q fever-related complications and mortality: data from a nationwide cohort.ArticleClin Microbiol Infect 2019; advance online publication (ahead of print)